What is it about?
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain.
Featured Image
Photo by Markus Kammermann on Unsplash
Why is it important?
In the present short review of the medical literature on this topic, we have evaluated their epidemiology, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.
Perspectives
Neuroendocrine neoplasms (NENs) of the breast are rare, accounting for less than 1% of all invasive breast cancers, although the reported incidence varies largely due to the lack of standardized diagnostic criteria [1].
Acquire Publications
Read the Original
This page is a summary of: Primary Neuroendocrine Neoplasms of the Breast: Case Report and Review of the Literature, Journal of Case Reports and Medical History, July 2025, Acquire Publications LLC,
DOI: 10.54289/jcrmh2500125.
You can read the full text:
Contributors
The following have contributed to this page
